Alembic Pharma gets EIR from USFDA for Karakhadi facility
Alembic Pharma gets EIR from USFDA for Karakhadi facility

Alembic Pharma gets EIR from USFDA for Karakhadi facility

Apurva Joshi Article rating: 4.7

Aleor Dermaceuticals Ltd, the 60:40 joint venture between Alembic Pharmaceuticals Ltd and Orbicular Pharmaceutical Technologies Pvt Ltd, has received an establishment inspection report (EIR) from United States Food & Drug Administration (USFDA).

How to select index funds?
How to select index funds?

How to select index funds?

DSIJ Intelligence Article rating: 3.7

Index investing has received major traction in the recent times. In this article, we would discuss as to how you should invest in index funds.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

DSIJ Intelligence Article rating: 3.8

The market opened in the green on May 6, 2020. The previous trading session witnessed the Sensex going down by 0.83 percent to end at 31,453.51 and the Nifty was down 0.95 percent to close at 9,205.60.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

DSIJ Intelligence Article rating: 3.6

The market opened in the green on May 6, 2020. The previous trading session witnessed the Sensex going down by 0.83 percent to end at 31,453.51 and the Nifty was down 0.95 percent to close at 9,205.60.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 4.3

The market opened in the green on May 6, 2020, overall volumes in futures & options currently stand at 1.93 crore contracts with a turnover of Rs. 10,08,239.80 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 4.1

The market opened in the green on May 6, 2020, overall volumes in futures & options currently stand at 1.93 crore contracts with a turnover of Rs. 10,08,239.80 crore.

Rallis India Q4FY20 revenue up by 2 per cent YoY
Rallis India Q4FY20 revenue up by 2 per cent YoY

Rallis India Q4FY20 revenue up by 2 per cent YoY

Nidhi Jani Article rating: 4.0

The company’s operations were interrupted at certain manufacturing facilities and depots, as a result of which, goods amounting to Rs 16.04 crore could not be dispatched to the domestic market. Further, international consignments were also interrupted due to the absence of transportation facilities in the last week of March 2020, which has resulted in the lower shipment of Rs 53.18 crore.

Index trend and stocks in action on May 06, 2020
Index trend and stocks in action on May 06, 2020

Index trend and stocks in action on May 06, 2020

DSIJ Intelligence-3 Article rating: 5.0

Going ahead, low of Tuesday’s session is going to be an important level to watch as a move below 9,190 level, would open gates for more downside towards 20-DMA, which is placed at 9,082 levels. On the upside, resistance is seen around 9,370-9,430 levels. Stocks in news: Wipro, Shilpa Medicare, Punjab & Sind Bank, Reliance Industries.

Markets may open with modest uptick
Markets may open with modest uptick

Markets may open with modest uptick

DSIJ Intelligence-3 Article rating: 5.0

SGX Nifty is indicating a mild positive start for Indian markets but that may be hard to sustain as the markets are vulnerable at higher levels. The triggers for Indian markets are likely to be more focussed on domestic stories as nearly six corporates are likely to report their earnings today which include Yes Bank.

RSS
First30103011301230133015301730183019Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR